Intracellular amyloid-β in Alzheimer's disease

LaFerla, Frank M., Green, Kim N., Oddo, Salvatore·2007·Nature Reviews Neuroscience

Cited by (1,005)

Items 501–600 of 1,005

  1. Ca2+-permeable AMPA receptor: A new perspective on amyloid-beta mediated pathophysiology of Alzheimer's disease
    Garry Whitehead, Philip L. Regan, Daniel J. Whitcomb, Kwangwook Cho · 2016 · Neuropharmacology
  2. Synthesis and Evaluation of Diphenyl Conjugated Imidazole Derivatives as Potential Glutaminyl Cyclase Inhibitors for Treatment of Alzheimer’s Disease
    Manman Li, Yao Dong, Xi Yu, Yue Li, Yongdong Zou, Yizhi Zheng, Zhendan He, Zhigang Liu, Junmin Quan, Xianzhang Bu et al. · 2017 · Journal of Medicinal Chemistry
  3. Mitigating Alzheimer’s Disease with Natural Polyphenols: A Review
    Roger Gaudreault, Normand Mousseau · 2019 · Current Alzheimer Research
  4. Dysregulation of intracellular trafficking and endosomal sorting in Alzheimer's disease: controversies and unanswered questions
    Toh, Wei Hong, Gleeson, Paul A. · 2016 · Biochemical Journal
  5. Neurodegenerative diseases – Understanding their molecular bases and progress in the development of potential treatments
    Magdalena Rowińska‐Żyrek, Milena Salerno, Henryk Kozłowski · 2014 · Coordination Chemistry Reviews
  6. Current strategies for the development of fluorescence-based molecular probes for visualizing the enzymes and proteins associated with Alzheimer’s disease
    Siyue Ma, Guang Chen, Jie Xu, Yuxia Liu, Guoliang Li, Tao Chen, Yulin Li, Tony D. James · 2020 · Coordination Chemistry Reviews
  7. Alzheimer’s disease patient brain extracts induce multiple pathologies in novel vascularized neuroimmune organoids for disease modeling and drug discovery
    Yanru Ji, Xiaoling Chen, Zhen Wang, Connor Joseph Meek, Jenna Lillie McLean, Yang Yang, Chongli Yuan, Jean‐Christophe Rochet, Fei Liu, Ranjie Xu · 2025 · Molecular Psychiatry
  8. Potential Role of the Ubiquitin-Proteasome System in Atherosclerosis
    Joerg Herrmann, Sandra M. Soares, Lilach O. Lerman, Amir Lerman · 2008 · Journal of the American College of Cardiology
  9. The Quest for Small Molecules as Amyloid Inhibiting Therapies for Alzheimer's Disease
    Hozefa Amijee, David I. C. Scopes · 2009 · Journal of Alzheimer s Disease
  10. Selenoprotein P and selenoprotein M block Zn2+-mediated Aβ42 aggregation and toxicity
    Xiubo Du, Haiping Li, Zhi Wang, Shi Qiu, Qiong Liu, Jiazuan Ni · 2013 · Metallomics
  11. Membrane Localization of β-Amyloid 1–42 in Lysosomes
    Rui‐Qin Liu, Qinghua Zhou, Shang‐Rong Ji, Qiang Zhou, Du Feng, Yi Wu, Sen‐Fang Sui · 2010 · Journal of Biological Chemistry
  12. Gold nanoparticle based dot-blot immunoassay for sensitively detecting Alzheimer's disease related β-amyloid peptide
    Chengke Wang, Dianjun Liu, Zhenxin Wang · 2012 · Chemical Communications
  13. Peroxisomal dysfunction in neurodegenerative diseases
    Doo Sin Jo, Dong‐Hyung Cho · 2019 · Archives of Pharmacal Research
  14. nELAV Proteins Alteration in Alzheimer's Disease Brain: A Novel Putative Target for Amyloid-β Reverberating on AβPP Processing
    Amadio, Marialaura, Pascale, Alessia, Wang, Jun, Ho, Lap, Quattrone, Alessandro, Gandy, Sam, Haroutunian, Vahram, Racchi, Marco, Pasinetti, Giulio Maria · 2009 · Journal of Alzheimer's Disease
  15. Neutral Peptides in the Gas Phase: Conformation and Aggregation Issues
    Eric Gloaguen, Michel Mons, Kirsten Schwing, Markus Gerhards · 2020 · Chemical Reviews
  16. Trehalose Protects from Aggravation of Amyloid Pathology Induced by Isoflurane Anesthesia in APPswe Mutant Mice
    Juan Perucho, Marı́a José Casarejos, Ana Gómez, Rosa Maria Solano, Justo Garcı́a de Yébenes, María A. Mena · 2012 · Current Alzheimer Research
  17. Neurochemical correlation between major depressive disorder and neurodegenerative diseases
    Gislaine Z. Réus, Stephanie E. Titus, Helena M. Abelaira, Sharon M. Freitas, Talita Tuon, João Quevedo, Josiane Budni · 2016 · Life Sciences
  18. Alzheimer’s disease and the autophagic-lysosomal system
    Chung, Kyung Min, Hernández, Nancy, Sproul, Andrew A., Yu, Wai Haung · 2019 · Neuroscience Letters
  19. Rapid Detection of Aβ Aggregation and Inhibition by Dual Functions of Gold Nanoplasmic Particles: Catalytic Activator and Optical Reporter
    Inhee Choi, Luke P. Lee · 2013 · ACS Nano
  20. Formation of highly toxic soluble amyloid beta oligomers by the molecular chaperone prefoldin
    Masafumi Sakono, Tamotsu Zako, Hiroshi Ueda, Masafumi Yohda, Mizuo Maeda · 2008 · FEBS Journal
  21. Increased susceptibility to Aβ toxicity in neuronal cultures derived from familial Alzheimer’s disease (PSEN1-A246E) induced pluripotent stem cells
    Enrique Armijo, César González, Mohammad Shahnawaz, Andrea Flores, Brian R. Davis, Claudio A. Soto · 2016 · Neuroscience Letters
  22. Nobiletin Reduces Intracellular and Extracellular β-Amyloid in iPS Cell-Derived Alzheimer’s Disease Model Neurons
    Junko Kimura, Kosuke Shimizu, Koji Kajima, Akihito Yokosuka, Yoshihiro Mimaki, Naoto Oku, Yasushi Ohizumi · 2018 · Biological and Pharmaceutical Bulletin
  23. Therapeutic effects of non-saponin fraction with rich polysaccharide from Korean red ginseng on aging and Alzheimer's disease.
    Soo Jung Shin, Yunkwon Nam, Yong Ho Park, Min-Jeong Kim, Eunbeen Lee, S. Jeon, Bong-Seok Bae, J. Seo, Sung-Lye Shim, Jong-Seok Kim et al. · 2021 · Free Radical Biology & Medicine
  24. Functional and Phenotypic Diversity of Microglia: Implication for Microglia-Based Therapies for Alzheimer’s Disease
    Yijun Xu, Ngan Pan Bennett Au, Chi Him Eddie Ma · 2022 · Frontiers in Aging Neuroscience
  25. Genetic and pharmacologic proteasome augmentation ameliorates Alzheimer’s-like pathology in mouse and fly APP overexpression models
    E. Sandra Chocrón, Erin Munkácsy, Harper S. Kim, Przemysław Karpowicz, Nisi Jiang, Candice E. Van Skike, Nicholas DeRosa, Andy Q. Banh, Juan Pablo Palavicini, Paweł Wityk et al. · 2022 · Science Advances
  26. Potential protection of curcumin against intracellular amyloid β-induced toxicity in cultured rat prefrontal cortical neurons
    Xiao‐Yan Qin, Yong Cheng, Long‐Chuan Yu · 2010 · Neuroscience Letters
  27. Selective dihydropyiridine compounds facilitate the clearance of β-amyloid across the blood–brain barrier
    Corbin J. Bachmeier, David Beaulieu‐Abdelahad, MICHAEL J. MULLAN, Daniel Paris · 2011 · European Journal of Pharmacology
  28. Proneurogenic Group II mGluR antagonist improves learning and reduces anxiety in Alzheimer Aβ oligomer mouse
    S H Kim, John Steele, Star W. Lee, Gregory Dane Clemenson, Tayler Carter, K Treuner, Reto A. Gadient, Pamela C. Wedel, Charles G. Glabe, Carrolee Barlow et al. · 2014 · Molecular Psychiatry
  29. Optimization of Curcumin-Loaded PEG-PLGA Nanoparticles by GSH Functionalization: Investigation of the Internalization Pathway in Neuronal Cells
    Ghislain Djiokeng Paka, Charles Ramassamy · 2016 · Molecular Pharmaceutics
  30. Investigations on isolated peptides by combined IR/UV spectroscopy in a molecular beam – structure, aggregation, solvation and molecular recognition
    Kirsten Schwing, Markus Gerhards · 2016 · International Reviews in Physical Chemistry
  31. Overexpression of matrix metalloproteinase-9 (MMP-9) rescues insulin-mediated impairment in the 5XFAD model of Alzheimer’s disease
    Archontia Kaminari, Nikolas Giannakas, Athina K. Tzinia, Effie C. Tsilibary · 2017 · Scientific Reports
  32. Somatostatin in Alzheimer's disease: A new Role for an Old Player
    Michael Solarski, Hansen Wang, Holger Wille, Gerold Schmitt‐Ulms · 2017 · Prion
  33. Human Prefoldin Inhibits Amyloid-β (Aβ) Fibrillation and Contributes to Formation of Nontoxic Aβ Aggregates
    Karin Margareta Sörgjerd, Tamotsu Zako, Masafumi Sakono, Peter C. Stirling, Michel R. Leroux, Takashi Saito, Per Nilsson, Misaki Sekimoto, Takaomi C. Saido, Mizuo Maeda · 2013 · Biochemistry
  34. Resonance light scattering as a powerful tool for sensitive detection of β-amyloid peptide by gold nanoparticle probes
    Chengke Wang, Dianjun Liu, Zhenxin Wang · 2011 · Chemical Communications
  35. Early-Onset and Robust Amyloid Pathology in a New Homozygous Mouse Model of Alzheimer's Disease
    Antje Willuweit, Joachim Velden, Robert Godemann, André Manook, Fritz Jetzek, Hartmut Tintrup, Gunther Kauselmann, Branko Zevnik, Gjermund Henriksen, Alexander E. Drzezga et al. · 2009 · PLoS ONE
  36. Herpes simplex virus type 2 infection induces AD-like neurodegeneration markers in human neuroblastoma cells
    Henrike Kristen, Soraya Santana, Isabel Sastre, Marı́a Recuero, Maria Jesus Bullido, Jesús Aldudo · 2015 · Neurobiology of Aging
  37. PI3K/AKT/mTOR/p70S6K Pathway Is Involved in Aβ25-35-Induced Autophagy
    Shengnuo Fan, Bei Zhang, Ping Luan, Beibei Gu, Qing Wan, Xiaoyun Huang, Wang Liao, Jun Liu · 2015 · BioMed Research International
  38. miR-137 attenuates Aβ-induced neurotoxicity through inactivation of NF-κB pathway by targeting TNFAIP1 in Neuro2a cells
    Dan He, Jun Tan, Jiewen Zhang · 2017 · Biochemical and Biophysical Research Communications
  39. Adiponectin controls the apoptosis and the expression of tight junction proteins in brain endothelial cells through AdipoR1 under beta amyloid toxicity
    Juhyun Song, Seong‐Min Choi, Daniel J. Whitcomb, Byeong Chae Kim · 2017 · Cell Death and Disease
  40. Metal-chelating benzothiazole multifunctional compounds for the modulation and 64 Cu PET imaging of Aβ aggregation
    Yiran Huang, Hong-Jun Cho, Nilantha Bandara, Liang Sun, Diana Tran, Buck E. Rogers, Liviu M. Mirica · 2020 · Chemical Science
  41. Implications of heparan sulfate and heparanase in neuroinflammation
    Xiao Li Zhang, Bo Wang, Jin‐Ping Li · 2014 · Matrix Biology
  42. Discovery and Structure Activity Relationship of Small Molecule Inhibitors of Toxic β-Amyloid-42 Fibril Formation
    Heiko Kroth, Annalisa Ansaloni, Yvan Varisco, Asad Jan, Nampally Sreenivasachary, Nasrollah Rezaei‐Ghaleh, Valérie Giriens, Sophie Lohmann, María Pilar López-Deber, Oskar Adolfsson et al. · 2012 · Journal of Biological Chemistry
  43. Reviewing reasons for the decreased CSF Abeta42 concentration in Alzheimer
    Petra, E. Spies · 2012 · Frontiers in bioscience
  44. Natural barrigenol–like triterpenoids: A comprehensive review of their contributions to medicinal chemistry
    Xinxin Zhang, Song Zhang, Yiren Yang, Da Wang, Huiyuan Gao · 2019 · Phytochemistry
  45. Graphene oxide improves postoperative cognitive dysfunction by maximally alleviating amyloid beta burden in mice
    Jiqian Zhang, Shasha Zhu, Peipei Jin, Yuting Huang, Qingqing Dai, Qianyun Zhu, Pengfei Wei, Zhilai Yang, Lei Zhang, Hu Liu et al. · 2020 · Theranostics
  46. Amyloid precursor protein in human breast cancer: An androgen‐induced gene associated with cell proliferation
    Kiyoshi Takagi, Shigehiro Ito, Toshiaki Miyazaki, Yasuhiro Miki, Yukiko Shibahara, Takanori Ishida, Mika Watanabe, Satoshi Inoue, Hironobu Sasano, Takashi Suzuki · 2013 · Cancer Science
  47. Drosophila Models of Alzheimer's Amyloidosis: The Challenge of Dissecting the Complex Mechanisms of Toxicity of Amyloid-β 42
    Koichi Iijima, Kanae Iijima‐Ando · 2008 · Journal of Alzheimer s Disease
  48. Neuroprotective activities of natural products from marine macroalgae during 1999–2015
    Alghazwi, Mousa, Kan, Yen Qi, Zhang, Wei, Gai, Wei Ping, Garson, Mary J., Smid, Scott · 2016 · Journal of Applied Phycology
  49. Characterization of a pectin from Lonicera japonica Thunb. and its inhibition effect on Aβ42 aggregation and promotion of neuritogenesis
    Liu, Qin, Fang, Jianping, Wang, Peipei, Du, Zhenyun, Li, Yanling, Wang, Shunchun, Ding, Kan · 2018 · International Journal of Biological Macromolecules
  50. Polyphenols with Anti-Amyloid β Aggregation Show Potential Risk of Toxicity Via Pro-Oxidant Properties
    Hatasu Kobayashi, Mariko Murata, Shosuke Kawanishi, Shinji Oikawa · 2020 · International Journal of Molecular Sciences
  51. Abnormalities of NBR1, a novel autophagy-associated protein, in muscle fibers of sporadic inclusion-body myositis
    Carla D’Agostino, Anna Nogalska, Mafalda Cacciottolo, W. King Engel, Valerie Askanas · 2011 · Acta Neuropathologica
  52. G Protein–Coupled Receptors, Cholinergic Dysfunction, and Aβ Toxicity in Alzheimer’s Disease
    Amantha Thathiah, Bart De Strooper · 2009 · Science Signaling
  53. Protein–Nanoparticle Interaction‐Induced Changes in Protein Structure and Aggregation
    Yuna Kim, Sung Min Ko, Jwa‐Min Nam · 2016 · Chemistry - An Asian Journal
  54. Metformin Attenuates Aβ Pathology Mediated Through Levamisole Sensitive Nicotinic Acetylcholine Receptors in a C. elegans Model of Alzheimer’s Disease
    Waqar Ahmad, Paul R. Ebert · 2016 · Molecular Neurobiology
  55. Synthesis and pharmacological evaluation of novel chromone derivatives as balanced multifunctional agents against Alzheimer's disease
    Fan Li, Jia‐Jia Wu, Jin Wang, Xuelian Yang, Pei Cai, Qiaohong Liu, Ling‐Yi Kong, Xiaobing Wang · 2017 · Bioorganic & Medicinal Chemistry
  56. Intracellular Calcium Dysregulation by the Alzheimer’s Disease-Linked Protein Presenilin 2
    Luisa Galla, Nelly Redolfi, Tullio Pozzan, Paola Pizzo, Elisa Greotti · 2020 · International Journal of Molecular Sciences
  57. On the role of v-ATPase V0a1–dependent degradation in Alzheimer Disease
    W. Ryan Williamson, P. Robin Hiesinger · 2010 · Communicative & Integrative Biology
  58. Erratum: How Do the Size, Charge and Shape of Nanoparticles Affect Amyloid β Aggregation on Brain Lipid Bilayer?
    Yuna Kim, Jihyun Park, Hyojin Lee, Jwa‐Min Nam · 2016 · Scientific Reports
  59. Anti-Alzheimer's disease potential of traditional chinese medicinal herbs as inhibitors of BACE1 and AChE enzymes
    Renhui Dai, Yingni Sun, Ruiling Su, Hongwei Gao · 2022 · Biomedicine & Pharmacotherapy
  60. Anti-herpetic tau preserves neurons via the cGAS-STING-TBK1 pathway in Alzheimer’s disease
    Vanesa R. Hyde, Chaoming Zhou, J R Muñóz y Fernández, Krishnashis Chatterjee, Pururav Ramakrishna, Amanda Lin, Gregory W. Fisher, Orhan T. Celiker, Jill Caldwell, Omer Bender et al. · 2025 · Cell Reports
  61. Pharmacotherapeutic targets in Alzheimer's disease
    Yif'at Biran, Colin Louis Masters, Kevin Jeffrey Barnham, Ashley Ian Bush, Paul Anthony Adlard · 2008 · Journal of Cellular and Molecular Medicine
  62. Adult hippocampal neurogenesis in aging and Alzheimer's disease
    Lorena Varela‐Nallar, Florencia C. Aránguiz, Ana C. Abbott, Paula G. Slater, Nibaldo C. Inestrosa · 2010 · Birth Defects Research Part C Embryo Today Reviews
  63. Early intervention in the 3xTg-AD mice with an amyloid β-antibody fragment ameliorates first hallmarks of Alzheimer disease
    Lydia Giménez‐Llort, Geovanny Rivera-Hernández, Marta Marin‐Argany, José Luis Sánchez‐Quesada, Sandra Villegas · 2013 · mAbs
  64. Alterations of brain and cerebellar proteomes linked to Aβ and tau pathology in a female triple-transgenic murine model of Alzheimer's disease
    Domenico Ciavardelli, Elena Silvestri, Adelaide Del Viscovo, Manuela Bomba, Danilo De Gregorio, María Moreno, Chiara Di Ilio, Fernando Goglia, Lorella M.T. Canzoniero, Stefano Luca Sensi · 2010 · Cell Death and Disease
  65. Potential protection of green tea polyphenols against intracellular amyloid beta-induced toxicity on primary cultured prefrontal cortical neurons of rats
    Xiao‐Yan Qin, Yong Cheng, Long‐Chuan Yu · 2012 · Neuroscience Letters
  66. Cholinergic System and Post-translational Modifications: An Insight on the Role in Alzheimer's Disease
    Touqeer Ahmed, Saadia Zahid, Aamra Mahboob, Syeda Mehpara Farhat · 2016 · Current Neuropharmacology
  67. Enhancing CNS Repair in Neurological Disease
    Xiaohua Xu, Arthur E. Warrington, Allan J. Bieber, Moses Rodriguez · 2011 · CNS Drugs
  68. Synaptic vesicle cycle and amyloid β: Biting the hand that feeds
    Saak Victor Ovsepian, Valerie B. O’Leary, László Záborszky, Vasilis Ntziachristos, James Oliver Dolly · 2018 · Alzheimer s & Dementia
  69. Upregulation of APP endocytosis by neuronal aging drives amyloid-dependent synapse loss
    Tatiana Burrinha, Isak Martinsson, Ricardo A. Gomes, Ana Paula Terrasso, Gunnar K. Gouras, Cláudia Guimas Almeida · 2021 · Journal of Cell Science
  70. ApoHRP-based assay to measure intracellular regulatory heme
    Hani Atamna, Marmik Brahmbhatt, Wafa Atamna, Gregory Shanower, Joseph M. Dhahbi · 2014 · Metallomics
  71. Yeast as a model for studying Alzheimer's disease
    Prashant Bharadwaj, Ralph Nigel Martins, Ian George Macreadie · 2010 · FEMS Yeast Research
  72. Neutralization of granulocyte macrophage colony-stimulating factor decreases amyloid beta 1-42 and suppresses microglial activity in a transgenic mouse model of Alzheimer's disease
    Manczak, Maria, Mao, Peizhong, Nakamura, Kazuhiro, Bebbington, Christopher, Park, Byung, Reddy, P. Hemachandra · 2009 · Human Molecular Genetics
  73. The neurotoxicity of amyloid β-protein oligomers is reversible in a primary neuron model
    Daisuke Tanokashira, Naomi Mamada, Fumiko Yamamoto, Kaori Taniguchi, Akira Tamaoka, Madepalli Krishnappa Lakshmana, Wataru Araki · 2017 · Molecular Brain
  74. Mulberry Diels-Alder-type adducts from Morus alba as multi-targeted agents for Alzheimer's disease
    Chunli Xia, Gui‐Hua Tang, Yan‐Qiong Guo, You‐Kai Xu, Zhi‐Shu Huang, Sheng Yin · 2018 · Phytochemistry
  75. Pioglitazone Reduces β Amyloid Levels via Inhibition of PPARγ Phosphorylation in a Neuronal Model of Alzheimer’s Disease
    Qiankun Quan, Yi‐Hua Qian, Xi Li, Ming Li · 2019 · Frontiers in Aging Neuroscience
  76. Bee Venom—A Potential Complementary Medicine Candidate for SARS-CoV-2 Infections
    Keneth Iceland Kasozi, Gniewko Niedbała, Mohammed A Alqarni, Gerald Zirintunda, Fred Ssempijja, Simon Peter Musinguzi, Ibe Michael Usman, Kevin Matama, ‏Helal F. Hetta, Ngala Elvis Mbiydzenyuy et al. · 2020 · Frontiers in Public Health
  77. Molecular mechanisms of resveratrol and EGCG in the inhibition of Aβ 42 aggregation and disruption of Aβ 42 protofibril: similarities and differences
    Fangying Li, Chendi Zhan, Xuewei Dong, Guanghong Wei · 2021 · Physical Chemistry Chemical Physics
  78. Role of the cannabinoid system in the transit of beta-amyloid across the blood–brain barrier
    Corbin J. Bachmeier, David Beaulieu‐Abdelahad, MICHAEL J. MULLAN, Daniel Paris · 2013 · Molecular and Cellular Neuroscience
  79. Carnosic acid attenuates apoptosis induced by amyloid-β 1–42 or 1–43 in SH-SY5Y human neuroblastoma cells
    Pengfei Meng, Hidemi Yoshida, Kunikazu Tanji, Tomoh Matsumiya, Fei Xing, Ryo Hayakari, Liang Wang, Kazushi Tsuruga, Hiroshi Tanaka, Junsei Mimura et al. · 2014 · Neuroscience Research
  80. Alzheimer’s disease: An update of the roles of receptors, astrocytes and primary cilia (Review)
    Ubaldo Armato, Balu Chakravarthy, Raffaella Pacchiana, James F. Whitfield · 2012 · International Journal of Molecular Medicine
  81. Changes in Proteasome Structure and Function Caused by HAMLET in Tumor Cells
    Lotta Gustafsson, Sonja Aits, Patrik Önnerfjord, Maria Trulsson, Petter Storm, Catharina Svanborg · 2009 · PLoS ONE
  82. Contribution of Yeast Models to Neurodegeneration Research
    Clara Pereira, Cláudia Bessa, Joana Soares, Mariana Leão, Lucı́lia Saraiva · 2012 · BioMed Research International
  83. Intraneuronal Amyloid Beta Accumulation Disrupts Hippocampal CRTC1-Dependent Gene Expression and Cognitive Function in a Rat Model of Alzheimer Disease
    Edward N. Wilson, Andrew R. Abela, Sonia Do Carmo, Simon T. M. Allard, Adam R. Marks, Lindsay A. Welikovitch, Adriana Ducatenzeiler, Yogita Chudasama, A. Claudio Cuello · 2016 · Cerebral Cortex
  84. Cereboost™, an American ginseng extract, improves cognitive function via up-regulation of choline acetyltransferase expression and neuroprotection
    Kyungha Shin, Haiyu Guo, Yeseul Cha, Young-Hwan Ban, Da Woom Seo, Young–Jin Choi, Tae‐Su Kim, Sung-Pyo Lee, Jong-Choon Kim, Ehn‐Kyoung Choi et al. · 2016 · Regulatory Toxicology and Pharmacology
  85. Synthesis and pharmacological evaluation of donepezil-based agents as new cholinesterase/monoamine oxidase inhibitors for the potential application against Alzheimer’s disease
    Fan Li, Zhimin Wang, Jia‐Jia Wu, Jin Wang, Sai‐Sai Xie, Jinshuai Lan, Wei Xu, Ling‐Yi Kong, Xiaobing Wang · 2016 · Journal of Enzyme Inhibition and Medicinal Chemistry
  86. Aβ “Stretching-and-Packing” Cross-Seeding Mechanism Can Trigger Tau Protein Aggregation
    Ruxi Qi, Yin Luo, Guanghong Wei, Ruth Nussinov, Buyong Ma · 2015 · The Journal of Physical Chemistry Letters
  87. The Role of Autophagy in the Correlation Between Neuron Damage and Cognitive Impairment in Rat Chronic Cerebral Hypoperfusion
    Wenying Zou, Yufei Song, Yumei Li, Yu Du, Xiaojie Zhang, Jianliang Fu · 2017 · Molecular Neurobiology
  88. Towards a better understanding of the cannabinoid-related orphan receptors GPR3, GPR6, and GPR12
    Paula Morales, Israa H. Isawi, Patricia H. Reggio · 2018 · Drug Metabolism Reviews
  89. Pharmacological interventions to improve cognition and adaptive functioning in down syndrome: strides to date.
    Hart, Sarah J., Visootsak, Jeannie, Tamburri, Paul, Phuong, Patrick, Baumer, Nicole, Hernandez, Maria‐Clemencia, Skotko, Brian G., Ochoa‐Lubinoff, Cesar, Liogier D'Ardhuy, Xavier, Kishnani, Priya S. et al. · 2017 · American Journal of Medical Genetics Part A
  90. Varicella Zoster Virus Infection of Primary Human Spinal Astrocytes Produces Intracellular Amylin, Amyloid-beta, and an Amyloidogenic Extracellular Environment.
    Andrew N. Bubak, Christina N. Como, Christina M. Coughlan, Noah R. Johnson, James E. Hassell, Teresa Mescher, Christy S. Niemeyer, R. Mahalingam, R. Cohrs, Timothy D. Boyd et al. · 2019 · Journal of Infectious Diseases
  91. Emerging Brain‐Pathophysiology‐Mimetic Platforms for Studying Neurodegenerative Diseases: Brain Organoids and Brains‐on‐a‐Chip
    Seokyoung Bang, Songhyun Lee, Nakwon Choi, Hong Nam Kim · 2021 · Advanced Healthcare Materials
  92. Disruption of the grid cell network in a mouse model of early Alzheimer’s disease
    Johnson Ying, Alexandra T. Keinath, Raphael Lavoie, Érika Vigneault, Salah El Mestikawy, Mark P. Brandon · 2022 · Nature Communications
  93. Targeted brain delivery of RVG29‐modified rifampicin‐loaded nanoparticles for Alzheimer's disease treatment and diagnosis
    Ruiyi Zhou, Lihong Zhu, Zhaohao Zeng, Rixin Luo, Jiawei Zhang, Rui Guo, Lei Zhang, Qunying Zhang, Wei Bi · 2022 · Bioengineering & Translational Medicine
  94. ER-stress in Alzheimer's disease: turning the scale?
    Kristina Endres, Sven Reinhardt · 2013 · Europe PMC (PubMed Central)
  95. Allele-specific RNAi Mitigates Phenotypic Progression in a Transgenic Model of Alzheimer's Disease
    Edgardo Rodríguez-Lebrón, Cynthia M. Gouvion, Steven A. Moore, Beverly L. Davidson, Henry Lauris Paulson · 2009 · Molecular Therapy
  96. Evaluation of the poly(ADP‐ribose) polymerase‐1 gene variants in Alzheimer's disease
    Hsin‐Ping Liu, Wei‐Yong Lin, Bor‐Tsang Wu, S. R. Liu, Wenfu Wang, Chon‐Haw Tsai, Chun‐Cheng Lee, Fuu‐Jen Tsai · 2010 · Journal of Clinical Laboratory Analysis
  97. Polymorphism −116 C / G of Human X ‐box‐Binding Protein 1 Promoter is Associated with Risk of A lzheimer's Disease
    Sheng‐Yuan Liu, Wei Wang, Zhiyou Cai, Lifen Yao, Zhongwei Chen, Changyi Wang, Bin Zhao, Ke‐Shen Li · 2013 · CNS Neuroscience & Therapeutics
  98. Synapses, synaptic activity and intraneuronal Aβ in Alzheimer’s disease
    Davide Tampellini · 2010 · Frontiers in Aging Neuroscience
  99. Oxidative stress caused by ozone exposure induces β-amyloid 1–42 overproduction and mitochondrial accumulation by activating the amyloidogenic pathway
    Luis Fernando Hernández-Zimbrón, Selva Rivas-Arancibia · 2015 · Neuroscience
  100. Icariin decreases both APP and Aβ levels and increases neurogenesis in the brain of Tg2576 mice
    F. Li, Hongxin Dong, Qihai Gong, Qin Wu, F. Jin, Jingshan Shi · 2015 · Neuroscience